Guggenheim analyst Sandy Draper maintains Medpace Hldgs (NASDAQ:MEDP) with a Buy and lowers the price target from $464 to $432.
Guggenheim Maintains Buy on Medpace Hldgs, Lowers Price Target to $432
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.